• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】19702

【品名】N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine

【CA登记号】

【 分 子 式 】C16H29NOSi

【 分 子 量 】279.4979

【元素组成】C 68.76% H 10.46% N 5.01% O 5.72% Si 10.05%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(II)

The cyclization of 4,4-diphenyl-2-cyclohexen-1-one (I) with N-benzyl-N-(butoxymethyl)-N-(trimethylsilylmethyl)amine (II) gives 2-benzyl-7,7-diphenylperhydroisoindol-4-one (III), which is debenzylated by hydrogenation with H2 over Pd/C to afford 7,7-diphenylperhydroisoindol-4-one (IV). The optical resolution of (IV) yields the desired enantiomer, which is finally condensed with 2-(2-methoxyphenyl)acetimidic acid ethyl ester tetrafluoroborate (V).

1 Peyronel, J.-F.; et al.; Synthesis of RP-67,580, a new potent nonpeptide substance P antagonist. Bioorg Med Chem Lett 1992, 2, 1, 37.
2 Lowe, J.A. III; Substance P antagonists. Drugs Fut 1992, 17, 12, 1115.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30325 4,4-diphenyl-2-cyclohexen-1-one C18H16O 详情 详情
(II) 19702 N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine C16H29NOSi 详情 详情
(III) 42930 (3aR,7aR)-2-benzyl-7,7-diphenyloctahydro-4H-isoindol-4-one C27H27NO 详情 详情
(IV) 42931 (3aR,7aR)-7,7-diphenyloctahydro-4H-isoindol-4-one C20H21NO 详情 详情
(V) 42932 ethyl 2-(2-methoxyphenyl)ethanimidoate C11H15NO2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

The condensation of racemic (3aRS,4RS,6SR,7aSR)-6-(hydroxymethyl)-4-(2-methoxyphenyl)perhydroisoindol-4-ol (I) with 2(S)-(2-methoxyphenyl)propionic acid (II) by means of hydroxybenzotriazole and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide in dichloromethane gives the diastereomeric amide (III), which is tosylated with tosyl chloride and submitted to chromatography yielding the (3aS,4S,6R,7aR)(S)-enantiomer (IV) as an optically pure isomer. Finally, this compound is allowed to react with potassium cyanide in hot DMSO affording RPR-111905. The starting compounds, the perhydroisoindole (I) and the propionic acid (II) have been obtained as follows: a) The cyclization of 5-(acetoxymethyl)-2-cyclohexen-1-one (V) with N-(butoxymethyl)-N-(trimethylsilylmethyl)benzylamine (VI) by means of trifluoroacetic acid (TFA) in dichloromethane gives racemic (3aRS,6SR,7aSR)-6-(acetoxymethyl)-2-benzylperhydroisoinol-4-one (VII), which is submitted to a Grignard condensation with 2-methoxyphenylmagnesium bromide (VIII) in THF yielding the racemic (3aRS,4RS,6SR,7aSR)(IX). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C in hot ethanol affording the desired racemic diol (I). b) The condensation of 2-(2-methoxyphenyl)acetic acid (X) with (4S,5S)-4-methyl-5-phenyloxazolidin-2-one (XI) by means of NaH, pivaloyl chloride and butyllithium gives the acylated oxazolidinone (XII), which is methylated regioselectively with sodium hexamethyldisylazane (Na-HMDS) and methyl iodide in THF yielding the 2(S)-methyl derivative (XIII). Finally, the hydrolysis of the oxazolidinone group of (XIII) with LiOH in THF-water affords the desired 2(S)-(2-methoxyphenyl)propionic acid (II).

1 Mutti, S.; et al.; Practical enantiospecific synthesis of RPR 111905: A novel non-peptide substance P antagonist. Tetrahedron Lett 1996, 37, 48, 8743.
2 Achard, D.; Peyronel, J.-F.; Tabart, M. (Aventis Pharma SA); Perhydroisoindole derivs. as antagonists of substance P. FR 2727411; JP 1998509970; US 5739351; WO 9616939 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 19697 (3aS,4R,6R,7aR)-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-1H-isoindol-4-ol C16H23NO3 详情 详情
(II) 19698 (2S)-2-(2-methoxyphenyl)propionic acid C10H12O3 详情 详情
(III) 19699 (2S)-1-[(4S,6R)-4-hydroxy-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-2H-isoindol-2-yl]-2-(2-methoxyphenyl)-1-propanone C26H33NO5 详情 详情
(IV) 19700 [(3aR,5R,7R,7aS)-7-hydroxy-7-(2-methoxyphenyl)-2-[(2S)-2-(2-methoxyphenyl)propanoyl]octahydro-1H-isoindol-5-yl]methyl 4-methylbenzenesulfonate C33H39NO7S 详情 详情
(V) 19701 [(1R)-5-oxo-3-cyclohexen-1-yl]methyl acetate C9H12O3 详情 详情
(VI) 19702 N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine C16H29NOSi 详情 详情
(VII) 19703 [(3aR,5R,7aS)-2-benzyl-7-oxooctahydro-1H-isoindol-5-yl]methyl acetate C18H23NO3 详情 详情
(VIII) 19704 bromo(2-methoxyphenyl)magnesium C7H7BrMgO 详情 详情
(IX) 19705 (3aS,4R,6R,7aR)-2-benzyl-6-(hydroxymethyl)-4-(2-methoxyphenyl)octahydro-1H-isoindol-4-ol C23H29NO3 详情 详情
(X) 19706 2-(2-methoxyphenyl)acetic acid 93-25-4 C9H10O3 详情 详情
(XI) 19707 (4S,5S)-4-methyl-5-phenyl-1,3-oxazolidin-2-one 17097-67-5 C10H11NO2 详情 详情
(XII) 19708 (4S,5S)-3-[2-(2-methoxyphenyl)acetyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C19H19NO4 详情 详情
(XIII) 19709 (4S,5S)-3-[(2S)-2-(2-methoxyphenyl)propanoyl]-4-methyl-5-phenyl-1,3-oxazolidin-2-one C20H21NO4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

Diels-Alder reaction between (E,E)-1,4-diphenylbutadiene (I) and propiolic acid (II) in xylene in the presence of hydroxyquinone (A) yields cyclohexadiene carboxylic acid (III), which is then converted into its methyl ester derivative (IV) by treatment with MeOH in the presence of H2SO4. Condensation of methyl ester (IV) with N-trimethylsilylmethyl-N-butoxymethyl-benzylamine (V) in CH2Cl2 in the presence of TFA provides hexahydro isoindole derivative (VI), which is first treated with trifluoromethane sulfonic acid in CH2Cl2, followed by treatment with NaOH, to furnish benzo[f]isoindole derivative (VII). Debenzylation of (VII) by reaction with ammonium formate and Pd/C gives compound (VIII), which is then converted into derivative (X) by coupling with 2-(2-methoxyphenyl)acrylic acid (IX). The target product is finally obtained by hydrolysis of methyl ester (X) with NaOH in EtOH. Intermediate (IX) can be obtained as follows: Treatment of 2-methoxyphenylacetic acid (XI) with thionyl chloride in refluxing EtOH provides ethyl ester (XII), which then reacts with paraformaldehyde and tetrabutylammonium iodide (TBAI) and K2CO3 in refluxing toluene to afford acrylate (XIII). Finally, ethyl ester (XIII) is hydrolyzed by treatment with refluxing NaOH.

1 Truchon, A.; Sounigo, F.; Peyronel, J.-F.; Zucco, M.; Mailliet, P.; Commercon, A.; Lebrun, A. (Aventis Pharma SA); 4,9-Ethano-benzo(f)isoindole derivs. as farnesyl transferase inhibitors. WO 9703050 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 13163 p-Dihydrobenzene; Hydroquinone 123-31-9 C6H6O2 详情 详情
(I) 46199 1-[(1E,3E)-4-phenyl-1,3-butadienyl]benzene C16H14 详情 详情
(II) 41770 propiolic acid 471-25-0 C3H2O2 详情 详情
(III) 46200 3,6-diphenyl-1,4-cyclohexadiene-1-carboxylic acid C19H16O2 详情 详情
(IV) 46201 methyl 3,6-diphenyl-1,4-cyclohexadiene-1-carboxylate C20H18O2 详情 详情
(V) 19702 N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine C16H29NOSi 详情 详情
(VI) 46202 methyl (7aS)-2-benzyl-4,7-diphenyloctahydro-3aH-isoindole-3a-carboxylate C29H31NO2 详情 详情
(VII) 46203 methyl (1R,8R,9S,13S)-11-benzyl-1-phenyl-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C29H29NO2 详情 详情
(VIII) 46204 methyl (1R,8R,9S,13S)-1-phenyl-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C22H23NO2 详情 详情
(IX) 37790 2-(2-methoxyphenyl)acrylic acid C10H10O3 详情 详情
(X) 46205 methyl (1R,8R,9S,13S)-11-[2-(2-methoxyphenyl)acryloyl]-1-phenyl-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C32H31NO4 详情 详情
(XI) 19706 2-(2-methoxyphenyl)acetic acid 93-25-4 C9H10O3 详情 详情
(XII) 46206 ethyl 2-(2-methoxyphenyl)acetate C11H14O3 详情 详情
(XIII) 46207 ethyl 2-(2-methoxyphenyl)acrylate C12H14O3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

Treatment of 3-oxo-6-phenylcyclohex-1-ene-1-carboxylic acid (I) with methyl iodide and DBU afforded methyl ester (II). Subsequent cycloaddition of (II) with N-n-butoxymethyl-N-(trimethylsilyl)methyl benzylamine (III) in the presence of trifluoroacetic acid gave the octahydroisoindole (IV). Addition of p-tolylmagnesium bromide (V) to the keto group of (IV) produced carbinol (VI), which was converted to the tetracyclic system (VII) by intramolecular cyclization in the presence of trifluoromethanesulfonic acid. Cleavage of the N-benzyl of (VII) group to give (VIII) was effected by transfer hydrogenation with ammonium formate and Pd/C. On the other hand, condensation of (2-methoxyphenyl)acetic acid (IX) with bis(dimethylamino)methane, followed by treatment with acetic anhydride generated the 2-arylpropenoic acid (X), which was converted to acid chloride (XI) employing oxalyl chloride and a catalytic amount of DMF. Coupling of acid chloride (XI) with the tetracyclic amine (VIII) yielded the corresponding amide (XII). The methyl ester group of (XII) was finally hydrolyzed with NaOH to the title carboxylic acid.

1 Dereu, N.; Sounigo-Thompson, F.; Commercon, A.; Martin, J.-P.; Bourzat, J.-D.; Capet, M.; Cheve, M.; Mailliet, P. (Aventis Pharma SA); Farnesyl transferase inhibitors. EP 0948483; WO 9829390 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 37784 3-oxo-6-phenyl-1-cyclohexene-1-carboxylic acid C13H12O3 详情 详情
(II) 37785 methyl 3-oxo-6-phenyl-1-cyclohexene-1-carboxylate C14H14O3 详情 详情
(III) 19702 N-benzyl-N-(butoxymethyl)-N-[(trimethylsilyl)methyl]amine; N-(butoxymethyl)(phenyl)-N-[(trimethylsilyl)methyl]methanamine C16H29NOSi 详情 详情
(IV) 37786 methyl (4R,7aS)-2-benzyl-7-oxo-4-phenyloctahydro-3aH-isoindole-3a-carboxylate C23H25NO3 详情 详情
(V) 35657 bromo(4-methylphenyl)magnesium 4294-57-9 C7H7BrMg 详情 详情
(VI) 37787 methyl (4R,7R,7aS)-2-benzyl-7-hydroxy-7-(4-methylphenyl)-4-phenyloctahydro-3aH-isoindole-3a-carboxylate C30H33NO3 详情 详情
(VII) 37788 methyl (1R,8R,9S,13S)-11-benzyl-1-(4-methylphenyl)-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C30H31NO2 详情 详情
(VIII) 37789 methyl (1R,8R,9S,13S)-1-(4-methylphenyl)-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C23H25NO2 详情 详情
(IX) 19706 2-(2-methoxyphenyl)acetic acid 93-25-4 C9H10O3 详情 详情
(X) 37790 2-(2-methoxyphenyl)acrylic acid C10H10O3 详情 详情
(XI) 37791 2-(2-methoxyphenyl)acryloyl chloride C10H9ClO2 详情 详情
(XII) 37792 methyl (1R,8R,9S,13S)-11-[2-(2-methoxyphenyl)acryloyl]-1-(4-methylphenyl)-11-azatetracyclo[6.5.2.0(2,7).0(9,13)]pentadeca-2,4,6-triene-9-carboxylate C33H33NO4 详情 详情
Extended Information